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1 |  INTRODUCTION
Spinal cord stimulation (SCS) was first reported as a 
treatment for pain a half‐century ago (Shealy, Taslitz et 
al., 1967). Since then, this use of electrical stimulation 
via leads placed in the spinal dorsal epidural space has 
become a valuable therapeutic tool for treating neuro-
pathic pain. The field of neuromodulation for chronic 
pain is rapidly expanding: in recent years, over 25,000 
neurostimulators have been implanted annually in the 
United States alone (Prager, 2010). While the econom-
ics points towards cost‐effectiveness of SCS (Kumar 
and Rizvi, 2013), the price of SCS devices is increasing. 
Furthermore, concomitant technological “advances”, in-
cluding complex stimulator designs and treatment pro-
tocols, have not correlated with improvements in patient 
outcomes (Zhang et al., 2014). This stalling of clini-
cal efficacy perhaps indicates that we have reached an 
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Abstract
Background and Objective: Despite the value of spinal cord stimulation (SCS) in 
treating some patients with focal neuropathic pain, technological advances in stimu-
lator design and treatment protocols have not correlated with significant improve-
ments in clinical outcomes. This may be because incomplete understanding of the 
mechanisms underlying SCS precludes improvement in clinical efficacy. In this brief 
review, we (a) review phenomenological effects of SCS, (b) review the literature on 
proposed spinal sites of action of SCS and (c) propose a novel hypothesis of mecha-
nism of action.
Results: Dorsal columns, dorsal roots and dorsal horns have each been proposed as 
spinal sites of action of SCS. We suggest that evidence in favour of the dorsal col-
umns or dorsal roots as the primary mediators of SCS is weak and propose that the 
dorsal horn is the crucial site of action. Furthermore, we hypothesize that, based on 
their location, and neurochemical and morphological properties, dorsal horn islet 
cells may mediate the effects of SCS.
Conclusions: The precise spinal mechanisms of action of SCS are still unknown. 
Dorsal horn islet cells have properties that position them to play a key role in analge-
sic effects of electrical stimulation. Understanding the mechanisms responsible for 
positive SCS effects are needed for successful translation into clinical dividends.
Significance: We review possible spinal mechanisms of action of spinal cord stimu-
lation for neuropathic pain, proposing that direct modulation of dorsal horn neurons 
is crucial. We suggest that mechanistic insights are needed for translation into more 
favourable clinical outcomes.
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absolute asymptote in the capacity of SCS therapy to im-
prove quality of life. Here, however, we suggest that it is 
our incomplete understanding of the mechanisms of SCS 
that has prevented further advancement.
If, as in drug discovery, high quality mechanistic insights 
lead to improved therapies (Howick et al., 2010), it would 
be useful to understand the mechanisms of action of SCS in 
modulating neuropathic pain. Here, we focus on potential 
spinal sites of action—that is, what is happening at the site 
of therapy delivery—recognizing that supraspinal mecha-
nisms also contribute to pain reduction (Bantli et al., 1975; 
Linderoth and Foreman, 1999). Furthermore, we will focus 
on conventional stimulation therapy, given the half century of 
experience with this treatment modality compared to the lim-
ited data on new SCS algorithms, such as high frequency and 
burst stimulation (Linderoth and Foreman, 2017). We first 
outline some physiological effects of SCS, then present evi-
dence against previously hypothesized sites of action: dorsal 
columns and dorsal roots. We then propose the dorsal horn as 
the likely key site of action, and finally hypothesize that SCS 
stimulates dorsal horn islet cells to reduce neuropathic pain.
1.1 | Neurophysiological and neurochemical 
phenomenology of SCS
It has been proposed that the therapeutic benefit of SCS re-
sults, in part, from changes in cortical activity: after all, pain is 
experienced by the brain. The supraspinal effects of SCS have 
been explored using imaging techniques. fMRI studies have 
shown that SCS leads to increases in activation of primary and 
secondary sensorimotor and posterior insular cortices (Stancak 
et al., 2008), and changes in “functional connectivity” between 
sensory and limbic areas (Deogaonkar et al., 2016). 15H2O PET 
studies have shown an increase in blood flow to the thalamus, 
bilateral parietal association areas, anterior cingulate cortex, 
and prefrontal areas with SCS (Kishima et al., 2010). These re-
sults have led to the suggestion that the cortical effects of SCS 
may down‐regulate the negative affective components of pain 
and modulate pain thresholds (Stancak et al., 2008; Kishima et 
al., 2010; Bentley et al., 2016). However, methodological vari-
ability, clinical heterogeneity across cohorts, and the diversity 
of cortical changes in response to SCS limits the robustness of 
conclusions; a recent systematic review highlighted the pau-
city of conclusive mechanistic insights relating to supraspinal 
effects (Bentley et al., 2016). Critically, it is unclear whether 
the effects seen in the cortex reflect a top‐down, cortical‐spinal 
process to mediate analgesia, or rather responses to a therapeu-
tic effect initiated at the spinal level (a bottom‐up, spinal‐corti-
cal mechanism), or a combination of the two.
In the spinal cord, electrophysiological studies have 
demonstrated that that there is an attenuation of nociceptive 
reflexes with SCS (Garcia‐Larrea et al., 1999; de Andrade et 
al., 2010), as well as some changes to sympathetic reflexes, a 
reduction in H‐reflex, and a reduction in a component of the 
somatosensory evoked potentials (de Andrade et al., 2010; 
Wolter et al., 2013). Interestingly, analgesia induced by SCS 
correlates with nociceptive reflex attenuation, interpreted as 
SCS causing broad inhibition of sensory afferent inputs (de 
Andrade et al., 2010), but any mechanistic relationship be-
tween reflex reduction and pain relief is not clear.
It has also been shown that SCS leads to neurochemical 
changes. These insights have largely come from animal mod-
els, where antagonists to GABA, serotonin, noradrenaline and 
dopamine each reduced some effects of SCS (Barchini et al., 
2012). For example, the suppression of tactile allodynia by 
SCS was found to be associated with GABA release in the dor-
sal horn (Stiller et al., 1996). A recent study showed that SCS 
led to reduced dorsal horn expression of an NMDA receptor 
subtype typically associated with peripheral sensitisation (Sun 
et al., 2017). In the same study, CB1 receptors were found to 
be responsible for the reversal of hyperalgesia seen with SCS 
(Sun et al., 2017). But again, any mechanistic relationship be-
tween SCS and these neurochemical changes is unknown.
Thus, it is clear that SCS can lead to pain reduction, ulti-
mately seen as changes in brain activity, and that SCS leads to 
neurochemical and physiological changes in the spinal cord. 
But the key mechanistic question remains: How does electri-
cal stimulation of the spinal cord lead to analgesia?
1.2 | Dorsal column stimulation?
Spinal cord stimulation was developed as a direct spin off 
of the gate control theory of pain (Melzack and Wall, 1965). 
Melzack and Wall postulated that afferent pain signals, trans-
mitted to the spinal cord via small fibres, are opposed by 
simultaneous activation of cutaneous touch signals, transmit-
ted via larger myelinated fibres. This low threshold cutane-
ous activity would result in the “gating” of dorsal horn output, 
thus reducing central pain perception. SCS stemmed from 
this theory: it was postulated that continuous stimulation of 
the axonal branches of Aβ fibres in the dorsal columns would 
lead to transmitter release via their spinal collaterals, which 
would then lead to inhibition of C fibre responses in dorsal 
horn neurons. This would close the gate and reduce central 
transmission of pain signals (Shealy, Taslitz et al., 1967; Wall 
and Sweet, 1967). This concept led to the initial term “dorsal 
column stimulation” (Shealy, Mortimer et al., 1967).
Clinical data lent indirect support to this theory: SCS in-
duces regional paraesthesias, thought to be via stimulation of 
large cutaneous afferents, and coverage of the painful area by 
paraesthesias is thought to be necessary for therapeutic effect 
(Barolat et al., 1993; North and Roark, 1995; Holsheimer, 
1998). This is consistent with the notion that SCS stimulates 
Aβ afferent fibres in the dorsal columns.
However, evidence suggests that the mechanisms of SCS 
are more nuanced. In particular, SCS primarily modulates 
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chronic neuropathic pain, doing little to alleviate acute no-
ciceptive pain as would be predicted from the gate control 
theory (Shealy, Mortimer et al., 1967; Shealy, Taslitz et al., 
1967). That is, this evidence conflicts with the concept that 
SCS acts simply through stimulation of large afferent fibres 
that would result in gating transmission from nociceptive 
afferents.
But the concept that direct stimulation of the dorsal col-
umns leads to analgesia is topographically appealing: dorsal 
columns are the intraspinal structures nearest to the elec-
trodes, so it is logical that they be stimulated by a midline epi-
dural electrode (Holsheimer et al., 1995; Holsheimer, 1998). 
Conceptually, this made sense: the extent to which a neuron 
or axon is excited by stimulation‐induced electric fields de-
pends not only on proximity to the stimulating electrode, but 
also on the structure’s electrical properties. Dorsal columns 
are longitudinal white matter tracts that should be activated 
by a longitudinally positioned cathode/anode combination 
(Oakley and Prager, 1976; Struijk et al., 1992; Brocker and 
Grill, 2013). And in animal models, sectioning of the dorsal 
column rostral to the site of stimulation leads to a reduction 
(although not elimination) in SCS effectiveness, suggesting 
that longitudinal fibres (of primary afferents or postsynaptic 
dorsal column pathways) play a role, along with modulation 
of the spinal cord itself which produces dorsal column‐in-
dependent analgesia (Barchini et al., 2012). But given the 
presence of postsynaptic dorsal column pathways (Rustioni, 
1973), the analgesic effects mediated by the dorsal columns 
may not be mediated by their direct stimulation.
Furthermore, the dorsal column stimulation hypothesis 
falls short with respect to two neuroanatomical properties. 
Firstly, dorsal column fibres are arranged such that the fas-
ciculus gracilis (which transmits afferent signals from the 
lower limbs) lies medial to the fasciculus cuneatus (which 
transmits afferent signals from the upper limbs) (Smith and 
Deacon, 1984). If SCS functions via stimulation of the dor-
sal columns, cervical SCS via a midline stimulating electrode 
should elicit paraesthesias in the lower limbs at lower thresh-
olds than those needed to elicit paraesthesias in the upper 
limbs. Instead, as stimulation amplitude is increased, par-
aesthesias are produced first bilaterally in the arms and then 
spread caudally (Meyerson, 1975). This indicates that if par-
aesthesias are produced by stimulation of the dorsal columns, 
then the lateral dorsal columns are stimulated at lower current 
intensities than the medially placed, nearer‐to‐lead fasciculus 
gracilis, an unlikely geometric condition. Secondly, given that 
dorsal column fibres run longitudinally, small adjustments in 
rostro‐caudal position of stimulation would result in a rela-
tively small change in the number of fibres being stimulated. 
Yet, the most favourable response is achieved by a relatively 
localized array of stimulating electrodes, with small rostral or 
caudal adjustments altering paraesthesias and clinical effects 
(Holsheimer, 1998). Thus, the anatomical geometry indicates 
that it is unlikely that the effects of SCS arise primarily from 
dorsal column stimulation.
1.3 | Dorsal root stimulation?
Given the positional sensitivity of the effects of SCS, it is 
logical to ask whether dorsal roots could be the primary site 
of action of SCS (Struijk et al., 1993). Modelling studies pre-
dict that the ventral curvature of incoming dorsal root affer-
ents should decrease their stimulation thresholds (Coburn and 
Sin, 1985; Struijk et al., 1993). Large myelinated dorsal root 
fibres have low stimulation thresholds and may be recruited 
prior to the dorsal columns by stimulation‐induced electrical 
fields (Struijk et al., 1993). While logical, several pieces of 
evidence suggest that dorsal root stimulation is unlikely to be 
clinically prominent in achieving therapeutic effects.
Firstly, when ramping up the amplitude of SCS, there is 
a large range in paraesthesia‐producing amplitudes prior to 
reaching the threshold for producing motor effects. But group 
Ia muscle spindle afferent fibres, which enter the spinal cord 
in a medial position, close to the position of SCS leads, have 
lower (or possibly similar in humans (Macefield et al., 1989)) 
thresholds compared to the largest, lowest threshold Aβ cu-
taneous fibres. If the effects of SCS are mediated by stimula-
tion of dorsal root afferents as they enter the cord and curve 
ventrally, then at low thresholds group Ia afferents should be 
activated leading to muscle contractions via monosynaptic 
reflex pathways. In addition, one would expect Ia afferent 
stimulation to produce proprioceptive errors. Yet, SCS typ-
ically elicits paraesthesias over a large range of stimulus am-
plitudes that are lower than those required to produce motor 
responses mediated by monosynaptic reflex pathways, and 
proprioceptive errors do not appear to be an effect of SCS 
(Rijken et al., 2013), making it unlikely that SCS functions 
by stimulating dorsal root afferents.
Secondly, focal SCS leads to paraesthesias in more than 
one dermatome—for example, a whole leg, indicating that it 
is not only local afferent fibres that are stimulated. While de-
viation of electrodes laterally can be used to directly stimulate 
individual dorsal roots, this produces dermatomal paraesthe-
sias, which may result in focal analgesia. In addition, the par-
aesthesias produced by direct dorsal root stimulation occur 
at stimulation amplitudes much lower than those required to 
produce paraesthesias by midline stimulation (Oakley and 
Prager, 1976; Barolat et al., 1993; He et al., 1994). Together, 
these differences indicate that the mechanism(s) underlying 
the usual midline or paramedian SCS therapy is unlikely to 
be mediated by dorsal root stimulation alone.
This does raise the question, though, of whether presynaptic 
inhibition (PSI) of afferent fibres may play a role in the analge-
sic effects of SCS, as has been proposed (Shimoji et al., 1982). 
PSI is depressed in models of neuropathic pain (Guo and Hu, 
2014), so it is logical to ask whether SCS acts to “restore” PSI 
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and thus reduce nociceptive input to the nervous system. But 
given that classical PSI requires stimulation of afferents, either 
in the dorsal columns or dorsal roots, it seems, based on the 
above, to be an unlikely primary mechanism of action. In ad-
dition, PSI occurs in direct response to stimulation and with a 
very short (<1 s) time course (Eccles et al., 1963), whereas the 
analgesic effects of SCS build up over minutes and continue 
following cessation of SCS (Oakley and Prager, 1976). While 
it is therefore unlikely that SCS acts via stimulating afferents to 
simply “restore” PSI–mediated gating of nociceptive afferent 
transmission, it is possible that the stimulation produces plastic 
changes (see Rudomin, 2009) in presynaptic inhibitory neurons 
that alter pain transmission (Wall and Sweet, 1967).
1.4 | Dorsal horn stimulation?
The dorsal horn is a critical site of initial pain processing and 
much focus has been on its role in neuropathic pain (Costigan 
et al., 2009). Neuronal circuits in the dorsal horn act as pro-
cessing hubs, analysing incoming sensory information for 
appropriate onward transmission to projecting neurons. It has 
been suggested that since midline epidural electrodes ensure 
the stimulation‐generated electrical fields would be greater 
in the superficial dorsal horn than in the adjacent dorsal root, 
this is the preferred target for SCS (Oakley and Prager, 1976). 
It is thus logical to ask whether the dorsal horn could be the 
primary site of action of SCS.
In rodent models of neuropathic pain displaying allodynia 
after sciatic nerve ligation, neurons of the deep dorsal horn (in 
particular wide dynamic range neurons and nociceptive‐spe-
cific neurons) exhibit hyperexcitability (Laird and Bennett, 
1993). SCS depresses hyperexcitability of wide dynamic 
range neurons of the dorsal horn, dampening both increased 
frequency of spontaneous discharge to cutaneous stimuli and 
after‐discharge (Yakhnitsa et al., 1999). This effect is long‐
lasting (over 10 min) and often peaks after the cessation of 
SCS, correlating with the clinical observation that relief af-
forded by SCS can outlast the period of stimulation (Wall 
and Sweet, 1967). It is not clear whether the inhibitory action 
of SCS on hyper‐excitable wide dynamic range neurons is 
mediated via reducing their excitatory input, increasing their 
inhibitory input, modulating the electrophysiological proper-
ties of these neurons, or a combination of these effects.
Animal models of neuropathic pain provide evidence 
that dysfunction of superficial dorsal horn inhibitory inter-
neurons, with resultant decreases in inhibition, contribute 
to neuropathic pain, including allodynia and hyperalge-
sia (for review, see Todd, 2010). Such a reduction in in-
hibition could lead to the hyperexcitability seen in wide 
dynamic range neurons. In rodent models of neuropathic 
pain, there are changes in local circuit function in the su-
perficial dorsal horn as shown, for example, by a reduc-
tion in afferent‐evoked inhibitory postsynaptic currents in 
lamina II interneurons (Moore et al., 2002). Whether this 
circuit dysfunction results from a loss of inhibitory inter-
neurons, reduced tonic excitation of inhibitory neurons 
(Balasubramanyan et al., 2006), depletion of GABA, or ab-
normal postsynaptic responses to GABA is not clear (Ibuki 
et al., 1997; Moore et al., 2002). In favour of the latter, 
the potassium chloride cotransporter KCC2, a regulator of 
intracellular chloride levels, is down‐regulated in rodent 
models of neuropathic pain such that GABA induces de-
polarizing rather than hyperpolarising responses, leading 
to neuronal excitation (Coull et al., 2003). Whichever the 
process(es), the specific identity of neurons involved is not 
known, although evidence points towards superficial dorsal 
horn inhibitory interneurons. Given that epidural stimula-
tion (at 1–2 Hz) has been shown to activate inhibitory in-
terneurons of lamina I–III—albeit with latencies consistent 
with trans‐synaptic (i.e. indirect) activation (Dubuisson, 
1989)—it seems logical to pursue the question of whether 
stimulation (at therapeutic frequencies) of inhibitory neu-
rons in this region is the main mechanism underlying the 
therapeutic benefit of SCS.
One population of neurons in the superficial dorsal horn 
deserves particular attention: islet cells. Islet cells in the su-
perficial dorsal horn have long dendritic trees (>400 μm) 
oriented in the rostro‐caudal direction with minimal medi-
olateral or dorsoventral projections (Todd and Lewis, 1986; 
Lu and Perl, 2003; Yasaka et al., 2007). As islet cells are 
GABAergic (Todd, 2010), it is plausible that their dysfunction 
could lead to the reduction in inhibition seen in neuropathic 
pain models. Furthermore, islet cells are tonically firing neu-
rons, owing to their relatively depolarized resting membrane 
potential (Lu and Perl, 2005). This is consistent with a postu-
lated circuit in which islet cells tonically inhibit central cells 
in lamina II that form excitatory synapses with vertical cells, 
which in turn innervate projecting neurons of lamina I that 
mediate pain signals (Lu and Perl, 2003; 2005) (Figure 1). In 
neuropathic pain, there is a reduction in excitatory input to 
islet cells (Balasubramanyan et al., 2006), which could result 
in reduced islet cell‐mediated transmission, and consequently 
lead to disinhibition of excitatory interneurons responsible 
for transmitting nociceptive signals (Todd, 2010).
Having said that, it is not clear what the target neurons 
of islet cells are, nor whether they are responsible for pre‐ 
or postsynaptic inhibition of their targets. It is known that 
some parvalbumin‐expressing neurons in the dorsal horn 
form axo‐axonic synapses (mediating presynaptic inhibition) 
with fibres from low threshold mechanoreceptors, and some 
islet cells do express parvalbumin (Hughes et al., 2012). And 
there is also evidence that islet cell axons form axo‐dendritic 
synapses (mediating postsynaptic inhibition) with neurons of 
the superficial dorsal horn (Gobel et al., 1980). Knowledge 
of the synapses formed by islet cell axons is necessary for un-
derstanding the role(s) of these neurons in neuropathic pain.
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2 |  HYPOTHESIS: SCS ACTIVATES 
ISLET CELL DENDRITES
In considering possible mechanisms of SCS, it is useful to 
examine how electrical fields produced by stimulation might 
affect neurons with large, polarized dendritic trees. These ef-
fects can be considered in light of studies using intracellular 
recordings from motoneurons with polarized dendritic trees 
in in vitro preparations of turtle spinal cords (Hounsgaard 
and Kiehn, 1993). In those studies, applying electrical fields 
across the longitudinal axes of dendrites led to depolariza-
tion of distal dendrites, generating calcium currents that led 
to sustained firing activity in the somata (Hounsgaard and 
Kiehn, 1993). Thus, electrical fields can have profound ef-
fects on activity and integration in morphologically complex 
neurons with active dendrites, and these effects critically de-
pend on the trajectory of dendrites in relation to the direction 
and geometry of the applied current (Jankowska, 2017).
As noted above, the dendrites of islet cells are oriented 
in the rostro‐caudal direction such that they would be 
spanned by SCS electrodes (Figure1). We suggest here that 
SCS mediates its therapeutic effect by exciting islet cell 
dendrites, thus increasing the spiking of islet cells. As such, 
SCS may “compensate” for the reduced excitation of islet 
cells seen in neuropathic pain models (Balasubramanyan 
et al., 2006). This concept is consistent with the demon-
stration that in neuropathic pain models that produce signs 
of tactile allodynia in rodents, intrathecally administered 
GABA agonists augment withdrawal thresholds and restore 
responses to SCS (Cui et al., 1996). Furthermore, in ani-
mal models of SCS, stimulation leads to an augmentation 
of GABA and reduction in glutamate release in the dorsal 
horn (Cui et al., 1997), and there is a reduction in excit-
ability of wide dynamic range neurons (Guan et al., 2010), 
putative synaptic targets of islet cells (Todd, 2010). That 
is, SCS may restore inhibition by enhancing dorsal horn 
GABAergic systems. We suggest that, given the geometry 
of stimulation, a prime candidate for these effects would 
be islet cells.
Interestingly, in patients with SCS, when the pulse width 
(duration) of stimulation is increased, the area of paraesthesias 
increases (Holsheimer et al., 2011). This indicates that struc-
tures with higher chronaxies – either because of their position 
in relation to the electrode or their intrinsic properties – are 
then recruited. It is known that passive dendrites have signifi-
cantly longer chronaxies than axons (Rattay et al., 2012), rais-
ing the possibility that the effects of increasing pulse widths 
result from increased recruitment of dendrites. In fact, longer 
pulse widths may preferentially recruit dendrites even in pas-
sive neurons (Stern et al., 2015). And if islet cell dendrites 
have active properties (voltage‐gated channels), it is likely 
that they would have lower chronaxies than passive dendrites 
(Stern et al., 2015), so a proportion, for example, would be 
stimulated with relatively low pulse widths. Thus the clinical 
effects observed when increasing pulse widths could be ex-
plained by increasing activation of islet cell dendrites.
F I G U R E  1  Schematic illustrating proposed mechanism of action of spinal cord stimulation for pain. Surface stimulation (black electrodes) 
produces electric fields (grey lines) that span dorsal horn islet cells (blue) leading to activation of their dendrites, depolarization, and thus trains of 
action potentials. Islet cells in turn would inhibit transmission between excitatory interneurons (shown as central cells, red and vertical cells, green), 
which would result in reduced activity of projection neurons (shown as lamina I projection neurons, yellow). (cf. Lu and Perl, 2005; Todd, 2017).
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Finally, can this hypothesized mechanism explain the time 
course of the effects of SCS, which can produce analgesic ef-
fects that outlast the duration of stimulation (Oakley and Prager, 
1976)? As in other regions of the nervous system, repetitive 
stimulation of spinal neurons can lead to long‐lasting changes 
in their activity (Mendell, 1984). In fact, it has been shown that 
there are plastic changes in the dorsal horn in a number of pain 
models (Todd, 2015). Can the repetitive stimulation of SCS 
lead to a “reversal” of these changes? It is conceivable that the 
hyperexcitability of some dorsal horn excitatory neurons asso-
ciated with pain can be reduced by SCS‐evoked enhancement 
of inhibition mediated by islet cells, and that this persistent in-
hibition leads to plastic changes and a reduction in excitability, 
thus reducing pain (Hu et al., 2006; Yasaka et al., 2010). These 
plastic changes would then outlast the electrical stimulation, 
thus explaining the time course of the clinical effects of SCS.
In summary, by correlating our understanding of the ef-
fects of electrical fields on neuronal excitability with den-
dritic morphology and known or postulated neuropathic pain 
mechanisms, we hypothesize that SCS works by stimulating 
dendrites of dorsal horn islet neurons. There are many unan-
swered questions raised by this hypothesis that can start to 
be addressed using methodologies in rodents once islet cells 
can be genetically targeted (like other spinal cord neurons, 
e.g. Chopek et al., 2018). For example, does SCS lead to 
stimulation of islet cells? This could be studied by recording 
genetically identified islet cells and applying external elec-
trical fields. Does islet cell excitation lead to analgesia? This 
could be studied using targeted stimulation (optogenetic or 
chemogenetic) of islet cells in animal models of neuropathic 
pain. Causality may then be inferred if: (a) directly activating 
islet cells mediates analgesia (demonstrating sufficiency) and 
(b) selectively inhibiting islet cells abolishes the therapeutic 
effects of SCS (demonstrating necessity). Having said that, 
such experiments will fail to capture the uniquely human af-
fective‐motivational component of pain. That is, manifesta-
tions of “therapeutic effect” in animal models of neuropathic 
pain may not translate to humans (Meyerson and Linderoth, 
2006). But identifying the spinal site of action of SCS will no 
doubt clarify how SCS modulates the sensory component of 
pain. And understanding the mechanisms by which electric-
ity impacts surrounding structures is the next logical step to 
advancing neuromodulation therapy.
3 |  CONCLUSION
The general phenomenology of neuropathic pain in pa-
tients and the therapeutic effects and limits of SCS for the 
treatment of neuropathic pain have been well described. 
To advance electrical stimulation therapies further, ani-
mal models aimed at studying neuronal circuits underlying 
neuropathic pain and how these circuits are modulated by 
SCS will undoubtedly provide invaluable understanding 
(see Linderoth and Foreman, 2017). Taking knowledge 
from phenomenological studies in patients to mechanis-
tic studies in animal models would logically lead to the 
development of mechanism‐based interventions that may 
lead to clinical gains in treating neuropathic pain in pa-
tients: a bedside to bench to bedside approach. That is, 
by moving from Platonic inductive reasoning of model-
ling to Aristotelian deductive reasoning of experimenta-
tion, we may ultimately understand the mechanisms of this 
therapy. Sound mechanistic insights have proved pivotal 
in improving pharmacological treatments (Howick et al., 
2010). Applying mechanistic approaches to neurostimula-
tion therapies will lead to real advances in SCS therapies 
that translate into clinical dividends. We could then emerge 
from this half‐century‐long impasse.
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